USANA Health Sciences Inc
NYSE:USNA

Watchlist Manager
USANA Health Sciences Inc Logo
USANA Health Sciences Inc
NYSE:USNA
Watchlist
Price: 21.34 USD -1.48%
Market Cap: $390.1m

Balance Sheet

Balance Sheet Decomposition
USANA Health Sciences Inc

Balance Sheet
USANA Health Sciences Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2002 Jan-2004 Jan-2005 Dec-2005 Dec-2006 Dec-2007 Jan-2009 Jan-2010 Jan-2011 Dec-2011 Dec-2012 Dec-2013 Jan-2015 Jan-2016 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Jan-2021 Jan-2022 Dec-2022 Dec-2023 Dec-2024 Jan-2026
Assets
Cash & Cash Equivalents
7
19
15
11
27
13
13
14
24
50
71
137
111
143
176
247
214
235
312
240
288
330
182
158
Cash Equivalents
7
19
15
11
27
13
13
14
24
50
71
137
111
143
176
247
214
235
312
240
288
330
182
158
Short-Term Investments
0
0
0
0
0
0
0
0
3
0
0
9
0
0
0
0
64
0
0
0
0
0
0
0
Total Receivables
0
1
4
4
5
8
9
6
12
10
14
19
17
15
22
17
16
10
10
9
10
8
9
0
Inventory
9
14
18
22
23
19
24
26
34
37
37
47
45
66
65
63
82
69
90
98
67
61
70
103
Other Current Assets
3
4
4
6
6
6
6
7
9
9
11
17
18
20
15
14
17
15
14
18
19
17
19
27
Total Current Assets
19
38
41
42
61
46
53
52
82
106
133
229
191
244
278
340
392
329
425
365
384
418
279
288
PP&E Net
18
20
23
23
30
52
57
57
166
61
62
59
71
88
101
103
92
127
128
126
118
117
116
94
PP&E Gross
18
20
23
23
30
52
57
57
166
61
62
59
71
88
101
103
92
127
128
126
118
117
116
0
Accumulated Depreciation
19
22
27
30
33
37
37
44
48
54
59
63
64
71
76
86
96
105
116
122
125
129
130
0
Intangible Assets
0
0
0
0
0
0
0
0
125
43
42
42
41
38
34
35
32
30
31
30
32
30
152
133
Goodwill
0
4
6
6
6
6
6
6
17
18
18
18
18
17
17
17
17
17
17
18
17
17
144
138
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
0
0
Other Long-Term Assets
2
2
2
3
3
5
7
9
174
17
13
20
30
35
41
24
22
15
39
39
45
31
57
89
Other Assets
0
4
6
6
6
6
6
6
17
18
18
18
18
17
17
17
17
17
17
18
17
17
144
138
Total Assets
39
N/A
65
+66%
72
+10%
74
+3%
100
+36%
109
+9%
123
+12%
123
+1%
217
+76%
245
+13%
267
+9%
369
+38%
351
-5%
423
+21%
471
+11%
519
+10%
555
+7%
517
-7%
641
+24%
578
-10%
597
+3%
633
+6%
748
+18%
743
-1%
Liabilities
Accounts Payable
3
5
5
5
10
8
7
6
6
8
7
10
8
10
9
12
10
13
18
14
11
10
12
17
Accrued Liabilities
4
6
7
9
11
14
15
12
19
17
21
26
28
35
35
34
40
41
53
51
36
33
43
0
Short-Term Debt
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
23
14
Other Current Liabilities
5
9
11
13
19
24
33
23
34
35
43
61
73
87
95
95
98
83
97
97
97
75
61
97
Total Current Liabilities
18
20
23
27
40
46
55
41
59
60
71
96
109
131
139
141
149
136
168
161
144
119
140
129
Long-Term Debt
3
0
0
0
0
28
35
7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
1
1
1
1
0
0
0
0
10
10
10
11
11
10
6
14
13
10
12
8
4
5
4
5
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54
53
Other Liabilities
0
0
0
0
0
2
1
2
1
1
1
1
1
1
1
1
1
19
19
14
14
12
18
23
Total Liabilities
21
N/A
21
-1%
24
+14%
28
+18%
40
+42%
76
+91%
91
+19%
49
-46%
70
+42%
71
+1%
82
+16%
108
+32%
120
+12%
142
+18%
145
+2%
156
+7%
163
+5%
165
+1%
199
+21%
183
-8%
162
-11%
136
-16%
216
+59%
210
-3%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Retained Earnings
15
29
35
36
44
26
24
56
90
119
135
200
166
215
265
288
330
306
383
345
392
445
479
0
Additional Paid In Capital
4
14
12
9
16
6
8
16
51
49
44
55
62
70
72
77
72
59
63
50
56
66
76
0
Other Equity
0
1
2
1
0
1
0
2
5
6
7
6
2
4
12
1
10
14
4
1
13
14
23
533
Total Equity
18
N/A
44
+145%
48
+8%
46
-4%
60
+32%
33
-45%
32
-3%
74
+134%
147
+97%
174
+18%
186
+7%
261
+40%
230
-12%
281
+22%
325
+16%
363
+12%
391
+8%
352
-10%
442
+26%
395
-11%
435
+10%
497
+14%
532
+7%
533
+0%
Total Liabilities & Equity
39
N/A
65
+66%
72
+10%
74
+3%
100
+36%
109
+9%
123
+12%
123
+1%
217
+76%
245
+13%
267
+9%
369
+38%
351
-5%
423
+21%
471
+11%
519
+10%
555
+7%
517
-7%
641
+24%
578
-10%
597
+3%
633
+6%
748
+18%
743
-1%
Shares Outstanding
Common Shares Outstanding
37
39
38
37
36
32
31
31
32
30
28
28
25
25
25
24
24
22
21
19
19
19
19
18
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett